daxibotulinumtoxinA

Revance Receives FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines
BioSpace
Fri, 04/22/22 - 10:15 am
Revance Therapeutics
glabellar lines
daxibotulinumtoxinA
Botox
Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'
Fierce Pharma
Mon, 10/18/21 - 11:10 am
Revance Therapeutics
FDA
daxibotulinumtoxinA
Botox
Daxi
AbbVie
Revance's frown-line injection latest to face regulatory delay after FDA can't hit inspection deadline
Fierce Pharma
Mon, 11/30/20 - 11:20 pm
ReVance
frown lines
aesthetics
FDA
daxibotulinumtoxinA